The emergence of HIV-1 group M subtype B in North American men who have sex with men was a key turning point in the HIV/AIDS pandemic. Phylogenetic studies have suggested cryptic subtype B circulation in the United States (US) throughout the 1970s 1,2 and an even older presence in the Caribbean 2 . However, these temporal and geographical inferences, based upon partial HIV-1 genomes that postdate the recognition of AIDS in 1981, remain contentious 3,4 and the earliest movements of the virus within the US are unknown. We serologically screened >2,000 1970s serum samples and developed a highly sensitive approach for recovering viral RNA from degraded archival samples. Here, we report eight coding-complete genomes from US serum samples from 1978-1979-eight of the nine oldest HIV-1 group M genomes to date. This early, full-genome 'snapshot' reveals that the US HIV-1 epidemic exhibited extensive genetic diversity in the 1970s but also provides strong evidence for its emergence from a pre-existing Caribbean epidemic. Bayesian phylogenetic analyses estimate the jump to the US at around 1970 and place the ancestral US virus in New York City with 0.99 posterior probability support, strongly suggesting this was the crucial hub of early US HIV/AIDS diversification. Logistic growth coalescent models reveal epidemic doubling times of 0.86 and 1.12 years for the US and Caribbean, respectively, suggesting rapid early expansion in each location
. We tested 2,231 of these samples from 1978 and found, by western blot, that 83 (3.7%) were positive for HIV-1 antibodies; of these, 20 were randomly chosen for attempted HIV-1 sequencing.
Low template number and degradation arising from long-term storage were major challenges for genomic analysis, as encountered previously with similar samples 10 : recovered RNA was generally below the limits of quantification and initial attempts at amplification of reversetranscribed viral RNA failed consistently and indicated that viral RNA survived in the 1970s samples only in short fragments. This led us to design an RNA 'jackhammering' approach to greatly increase both the ability to detect viral RNA-positive samples and to recover complete genomic HIV-1 sequences from them. Briefly, we used large panels of primers to amplify many short fragments in separate pools, such that amplicons overlapped between but not within each pool (Extended Data Fig. 1 and Supplementary Table 1) . Each pool's amplicon set filled gaps between those of complementary pools, with the entire panel providing complete genomic coverage. Moreover, a preliminary, multiplex amplification step greatly concentrated target RNA before final amplification and sequencing.
Three samples from SF and five from NYC provided sufficient data to assemble coding-complete sequences. Bayesian phylogenetic analyses of these HIV-1 genomes ( Fig. 1 and Extended Data Fig. 2 ) showed that although they were the oldest sampled outside Africa, they do not fall on the deepest branches even within subtype B. Instead, the 1970s genomes and the US epidemic as a whole were phylogenetically nested within the more genetically diverse, older subtype B epidemic in Caribbean countries. Separate analyses of gag, pol and env sequences also placed the US sequences in a strongly supported monophyletic clade nested within the paraphyletic Caribbean subtype B sequences from Haiti, Dominican Republic, Jamaica, Trinidad and Tobago and Haitian immigrants in the US (Extended Data Figs 3, 4) . Molecular clock phylogeographic analysis of the complete genome data supported a subtype B ancestor in the Caribbean (posterior probability > 0.99) dating to 1967 (95% credibility interval 1963-1970) (Extended Data Table 1 ). This provided genome-wide evidence that the epidemic moved from the Caribbean to the US rather than from the US to the Caribbean 2 . Location transition estimates recovered a relatively precise date (1971 (1969-1973) , Extended Data Table 1 ) for the HIV-1 jump from the Caribbean, very shortly before the US most recent common ancestor (MRCA). This narrow timing is aided by the basal relationship of a very close relative from the Caribbean (sequence 'H6' from an individual who entered the US from Haiti in 1981) 2 (Extended Data Fig. 2 ). The probability density of the date of introduction to the US overlaps with the deep branching structure in Caribbean diversity ( Fig. 1 and Extended Data Fig. 3 ), indicating that the US clade emerged from the Caribbean epidemic during its early growth phase. We estimated a relatively fast logistic growth rate of 0.62 (0.26-0.99) yr −1 within the Caribbean population (Fig. 2) . That of the US population was even , in line with a precipitous spread among existing high-risk sexual networks. These mean growth rate estimates corresponded to doubling times of 1.12 years and 0.86 years for the Caribbean and the US, respectively; both the more rapid and longer growth in the US appear to have contributed a higher number of 'effective infections' (Fig. 2) , with the US overtaking the Caribbean by around 1977 despite the later HIV-1 emergence in the US.
Molecular clock analyses of larger numbers of env sequences revealed similar time of the most recent common ancestor (TMRCA) estimates for the key nodes (Fig. 3 , Extended Data Table 1 and Extended Data  Figs 5, 6 ). Interestingly, our modest snapshot of 1970s sequences from NYC and SF (Fig. 3, Extended Data Fig. 5b ) encompassed the full diversity exhibited by HIV-1 sequences from later years (that is, it shares the same MRCA as larger sequence sets sampled in later years): all post-1985 US sequences are nested within the early diversity captured by the limited number of 1970s sequences we recovered (Extended Data Fig. 6) .
A phylogeographic reconstruction including only those US sequences sampled from known locations between [1978] [1979] [1980] [1981] [1982] [1983] [1984] (Fig. 1 ) demonstrated that the NYC epidemic was already relatively mature and genetically diverse by 1979, tracing back to an MRCA estimated at 1972 (1970-1974) and there is strong support for the idea that the US subtype B ancestor circulated in NYC (posterior probability = 0.99). Indeed, the extensive genetic diversity in the US (and in NYC in particular) in 1978-1979 can be explained only by several years of circulation of the virus before 1978-1979. Using sequences sampled from NYC, North Carolina and California relatively late in the epidemic (comparable to the 1978-1984 East coast, West coast and Southern sampling), we still inferred a US ancestor in NYC, but with only modest support that prevents us from drawing firm conclusions (pp = 0.67, Extended Data Figure 6b and Extended Data Table 1) . As a generality, early samples close to the deep branching structure are essential to confidently reconstruct the initial spatiotemporal expansion dynamics in exponentially growing populations.
Compared to NYC, the SF epidemic in 1978 appeared to have been established more recently (Figs 1, 3 , and Extended Data Figs 2b, 5b). It is striking that all three independently detected complete HIV-1 genomes we found are so closely related; moreover, they form a cluster with three partial env sequences sampled in SF during the same period 10 (Extended Data Fig. 5b ). This suggests that the bulk of the HIV-1 infections in SF in 1978 traced back to a single introduction from NYC in around 1976 (consistent with the lower HIV-1 seroprevalence in the SF cohort).
The sampled sequences thus reveal a series of key founder events in the genesis of subtype B (for example, Fig. 3 and Extended Data Table 1) , with the epidemic spreading from the African HIV-1 group M epicentre to the Caribbean by about 1967, from the Caribbean to NYC by about 1971 and from NYC to SF by about 1976, quickly followed by extensive geographical mixing in the US and beyond.
Reports of one cluster of homosexual men with AIDS linked through sexual contact were important in suggesting the sexual transmission route of an infectious agent before the identification of HIV-1 (refs 5, 11) . Beginning in California, CDC investigators eventually connected 40 men in ten American cities to this sexual network. Investigators placed one man with Kaposi's sarcoma near the centre of a sociogram representing this cluster and identified him as 'Patient 0'-a 'non-Californian AIDS patient' and a possible 'carrier' of an infectious agent (Extended Data Fig. 7 ). Before publication, Patient 'O' was the abbreviation used to indicate that this patient with Kaposi's sarcoma resided 'Out(side)-of-California. ' As investigators numbered the cluster cases by date of symptom onset, the letter 'O' was misinterpreted as the number '0, ' and the non-Californian AIDS patient entered the literature with that title 12 . Although the authors of the cluster study repeatedly maintained that Patient 0 was probably not the 'source' of AIDS for the cluster or the wider US epidemic, many people have subsequently employed the term 'patient zero' to denote an original or primary case, and many still believe the story today 13 . We therefore recovered the complete HIV-1 genome of Patient 0 and examined it against the backdrop provided by the 1970s sequences.
Although labelled as the cluster study's 'index patient' , Patient 0 was neither the first AIDS case to come to CDC researchers' Letter reSeArCH attention, nor the first to display symptoms. In general, the CDC numbered cases in the order that the reports reached the agency from different cities and employed the terms 'cases' and 'patients' interchangeably. Patient 0, until he was linked to the cluster and took on his new name, was Case (or Patient) 057. The cluster study's LA 6 was the CDC's Case 032, and several cases in the New York section of the cluster 5 (Extended Data Fig. 7 ) were also reported before Patient 0 (and thus brought to investigators' attention first): NY 3 was Case 001, NY 2 was Case 002, NY 6 was Case 010 and NY 5 was Case 053 (ref. 14).
The information available for CDC investigators to establish symptom onset dates was often fragmentary and thus resisted uniform categorization. Sometimes onset was determined on the basis of lymphadenopathy, other times by the appearance or diagnosis of Kaposi's sarcoma or Pneumocystis carinii pneumonia. Investigators were unable to link to the cluster several NYC-based cases that had much earlier dates of symptom onset. . Unlike the initial reports of the cluster, media coverage of Shilts's book strongly insinuated that this individual was the source of the North American epidemic and an exemplar of dangerous disease transmission 18 -ideas which found a global audience (Supplementary Discussion). However, we found that the HIV-1 genome from this individual appeared typical of US strains of the time and was not basal to the US diversity, let alone to the deeper Caribbean subtype B diversity, in a manner that might be suggestive of a special role (Figs 1, 3) . In short, we found no evidence that Patient 0 was the first person infected by this lineage of HIV-1.
In addition to donating plasma for analysis, Patient 0 provided investigators with the names of nearly 10% of his sexual partners over several years 5 , while many other cluster patients were unable to share more than a handful of names 16 . This strongly suggests that ascertainment bias contributed to his central role in the cluster study and its diagrammatic representation. Later research would also call into question the cluster study's estimated average latency period of 10.5 months between sexual contact and symptom onset, with a revised average incubation period approaching 10 years for MSM. In retrospect, the study's sociogram (Extended Data Fig. 7 ) almost certainly depicted the sexual contacts of these men years after they had contracted HIV-1 (ref. 19) (Supplementary Discussion). Other East coast HIV-1 sequences fall much closer to the main early-California clade we identify than does that of Patient 0 (Fig. 3) . Thus, while he did link AIDS cases in New York and Los Angeles through sexual contact, our results refute the widespread misinterpretation that he also infected them with HIV-1.
Much like historical reconstructions, phylogenetic inferences are often generated from data collected long after the critical events occurred. Our work highlights the importance of complete viral genomes from early archival specimens, carefully contextualized through historical analysis, without which this detailed picture of these early landmarks in the HIV/AIDS pandemic would not have been possible.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. , identified as part of the present study as positive for antibody to HIV-1, were assayed. The New York City samples were from 1978 and 1979 though no complete genomic sequences from 1978 were developed. The San Francisco samples were all from 1978. RNA recovered from samples from both NY and SF was generally undetectable when assaying 5-μ l aliquots in a Qubit 2.0 fluorometer using the Qubit RNA HS reagents (detection limit, 250 pgμ l
−1
). Additionally, a sample of peripheral blood mononuclear cells (PBMCs) and a sample of serum were both assayed; these had been collected from a single individual in 1983 (Patient 0), and the samples were stored at CDC Atlanta. Other than Patient 0, now deceased, the data recorded were unlinked to individual identifiers and the work was approved by the Human Subjects Protection Program at the University of Arizona.
Four panels of degenerate primers (Supplementary Table 1 and Extended Data Fig. 1 ) were designed using a suite of North American subtype B sequences. We aimed to design primers able to amplify both conserved regions and predictably variable sites. Primers within each panel were designed to generate sequence from the 5′ end of gag to the 3′ end of nef and were designed to amplify overlapping fragments. Two panels 'HIVL' (n = 25) and 'HIVLb' (n = 22) were designed to amplify fragments of approximately 500-650 bases in length. Two other panels 'HIVM' (n = 50) and 'HIVR' (n = 46) were designed to amplify fragments of approximately 200-320 bases in length.
Nucleic acids from 100-μ l aliquots of serum (or PBMCs in the case of Patient 0) were isolated using the QIAamp viral RNA mini kit (Qiagen) with 5 mcg added carrier RNA. Serum samples were then treated with DNase I (Invitrogen, Life Technologies) before reverse transcription. PBMC nucleic acids were left untreated. Proviral DNA from Patient 0's PBMCs was amplified with all four primer panels and from multiple separate isolations. Amplification was achieved using Invitrogen platinum Taq DNA polymerase high fidelity (Life Technologies) and run for 55 cycles at an annealing temperature of 52 °C. Additionally, attempts were made to amplify longer fragments using PCR supermix high fidelity (Life Technologies) and forward and reverse primers matched from the HIVLb primer panel for long fragment length followed by nesting with primers for slightly shorter fragment length. A single fragment of slightly more than 7,000 bases was generated after multiple attempts with multiple primer combinations and cloned using the Invitrogen TOPO XL PCR cloning kit (Life Technologies). Fragments of individual clones were then amplified using HIVLb forward and reverse primers matched to give approximately 1,000-base overlapping fragments and then sequenced. RNA jackhammering. RNA jackhammering of the serum samples proceeded as follows: aliquots of RNA extract were reverse transcribed using the GoScript reverse transcription system (Promega) using a program of 4 cycles of 50 °C for 30 min followed by 55 °C for 30 min and a final incubation at 85 °C for 10 min. Primers used were pools of reverse primers from widely spaced amplicons (Supplementary Table 1 , Extended Data Fig. 1) , typically nine or ten primers per pool in a single reaction tube, with the wide spacing abrogating the possibility of incorporation of an internal primer into any given amplicon. Reverse transcription products were then briefly amplified in multiplex reactions in the pool-specific tube (denaturation for 3 min at 94 °C followed by 30 cycles of 94 °C for 30 s, 52 °C for 30 s, 68 °C for 30 s, and a final extension of 68 °C for 5 min) with matching forward primer pools (a 'preliminary amplification' step). Sequences were then amplified from individual aliquots taken from the pool-specific tubes, via single primer pairs (denaturation for 3 min at 94 °C followed by 40 cycles of 94 °C for 30 s, 52 °C for 30 s, 68 °C for 30 s, and a final extension of 68 °C for 5 min). Two separate isolates were amplified from each sample in this manner, with a minimum of one amplification with each primer panel per isolate. Five out of the 33 (15%) of the NY sera assayed yielded complete HIV-1 genomic data as did 3 out of the 20 (15%) SF sera, suggesting that levels of viral RNA preservation were very similar in each collection.
In Extended Data Fig. 1 we schematically illustrate the RNA jackhammering approach and its advantages over standard RT-PCR procedures for degraded, low input samples. For a conventional RT-PCR approach with a fairly long amplification product we would perform reverse transcription and obtain one potentially amplifiable cDNA product. We would then aliquot ~ 10% of the reverse transcription product for amplification in a PCR reaction with forward and reverse primers. Even if the single cDNA product made it into the PCR reaction, the desired amplification product would be too long and a PCR amplicon would therefore not be obtained. For RT-PCR with a shorter amplification product, more appropriately sized given the damaged RNA in the sample, there was still a 90% chance that it would be deemed a negative sample since most aliquots will not contain the rare cDNA product. Using multiple primer sets would increase the chance of a PCR-positive result, but most PCR reactions remained negative because most aliquots lack target cDNA. Even with a 10 primer-pair pool and 10 final PCR reactions, there may be no amplified product. The RNA jackhammering approach targets large panels of appropriately short amplicons, uses discrete pools of non-overlapping primers pairs for reverse transcription, and includes a crucial multiplex preamplification step to ensure that each aliquot contained ample template molecules for the final PCR amplification (a separate reaction for each primer pair in the entire panel).
Sequencing was performed at the University of Arizona Genetics Core using an ABI 3730XL. The Patient 0 sample contained considerable heterogeneity (mixed bases) both in proviral assembly and in viral RNA amplification. Heterogeneity in the NY and SF samples (all sequences derived from viral RNA) was low. In all cases consensus sequences were used in the phylogenetic analyses. Primer sequences were computationally removed from all sequence data before assembling genomic consensus sequences, which yielded coding-complete genomic data with exception of a few small gaps and the 3′ end of the nef gene (Supplementary Table 2 ). Validation of the jackhammering approach. To validate this approach we obtained seed stock samples from the NIH AIDS Reagent program of subtype B viruses from the US (US657) and Haiti (HT599) and applied a jackhammering approach with independent runs of both the HIVM and HIVR primer panels (Extended Data Fig. 8 ).
For US657 we recovered, in total, from both runs combined, 8, 194 nt of high quality data. HIVM and HIVR are independent runs with completely different primer sets, yet where the data overlapped, they were > 99.9% similar. Moreover, the few heterogeneities did not line up with heterogeneous primers but fell in regions between primers, demonstrating that differences could not be attributed to the incorporation of primers into the recovered sequences. This was expected both because the wide spacing of amplicons within a single pool of primer pairs prevents incorporation of primers within amplified products and because all primer sequences from final amplification products were computationally removed from the sequences before assembly of genomic sequences. There are 3,354 bases in the published US657 sequence. Our data covered about 90% of the 3,354 bases of previously published US657 sequence (GenBank accession number U04908) and all of our individual amplicons in the region of overlap had US657 as the highest BLAST hit and were > 99% similar to the published sequence.
For HT599 the HIVM and HIVR primer panels developed 8,545 nt of data, 99.6% of the target. The HIVM-derived sequence was > 99.9% similar to the HIVR-derived sequence. We recovered 100% of the overlap with the previously published HT599 sequence (2,881 nt, GenBank accession number U08447) with 99.5% similarity.
To evaluate discrepancies between the jackhammering-recovered sequences and both US657 and HT599, we compared consensus sequences of combined HIVM and HIVR data with the respective published sequences by adding them to our complete genome alignment and reconstructing a maximum likelihood tree (Extended Data Fig. 8a ). As expected, the independently generated sequences from each virus clustered very closely and only had short tips from their common ancestors, resulting from a very small number of substitutions in their overlapping regions. In a root-to-tip analysis (Extended Data Fig. 8b ), our sequences (with a target symbol) were associated with somewhat smaller residuals than the published sequences (with a circle), indicating that our data are likely to be more accurate and, importantly, cannot contain primer remnants as this would result in much larger residuals. Sequence data. To construct the data sets for the analyses shown in Fig. 1 In all cases sequences were manually aligned using Se-Al (http://tree.bio. ed.ac.uk/software/seal/). All sequence alignments, input files, tree files and primer sequences are available at the Dryad Digital Repository (doi:10.5061/ dryad.7mv7v). Recombination analysis and maximum likelihood tree reconstruction. Maximum likelihood phylogenies were reconstructed using RAxML under on a general time-reversible model of substitution with gamma distributed rate variation among sites 20 . Bootstrap support values were calculated using 1,000 pseudoreplicates. To detect the presence of recombination, we first performed the Phi test 21 on every data set (Extended Data Table 1 ). When the null hypothesis of absence of recombination was rejected (P < 0.05), we subsequently analysed the data set using RDP4 (ref. 22 ) and produced new alignments in which the minor recombinant regions were deleted from putative recombinants. Re-analyses of these 'recombination-free' data sets using the Phi test confirmed the absence of detectable recombination signal (P > 0.05, Extended Data Table 1 ). Bayesian phylogenetic inference. Time-measured phylogeographic histories were reconstructed using a Bayesian phylogenetic inference approach implemented in BEASTv1. 8.2 (ref. 23) . Our full probabilistic model combined sequence substitution over an unknown phylogeny calibrated in time units using a molecular clock process with dated tips 24 , a coalescent tree prior and a discrete diffusion process among discrete location states 25 . For the sequence substitution process, we used the same model as for the maximum likelihood reconstructions. We accommodated rate variation among lineages using a lognormal distribution in an uncorrelated relaxed molecular clock model 26 and integrated out each sampling date over an uncertainty interval of one year. Visual inspections of root to tip divergence as a function of sampling time using TempEst 27 indicated a strong temporal signal with no clear outlier sequences (Extended Data Fig. 9) .
For most analyses, we flexibly modelled changes in effective population size through time by specifying a Bayesian skygrid non-parametric tree prior with a grid of 50 years and yearly effective population size parameters 28 . (The notion of 'effective population size' , or 'effective infections' in epidemiological applications, comes from population genetics, and is typically lower than the full (that is, census) population size, reflecting, for example, variance in reproductive success among individuals-transmissions to new hosts in this context). To estimate viral population growth rates in both the Caribbean and US populations, we fitted a 'nested' coalescent model to the data set with the largest taxon sampling (env 133). This model fits a constant-logistic demographic function 29 to the genealogy excluding the US clade. The initial constant phase was included in the model to accommodate the deep branching between the subtype B sequences and the African subtype D outgroup sequences. Nested within this model, a separate logistic growth model was fitted to the US clade in the genealogy.
The process of discrete diffusion among locations was modelled using a general non-reversible substitution model 30 . In our analyses including the African subtype D outgroup lineages, we set the root state frequency to one for the African state and zero for all other possible discrete states. We obtained estimates of the transitions among locations (Markov jumps) using a stochastic mapping implementation capable of inferring the complete Markov jump history 31, 32 . We approximate the posterior distribution for our full probabilistic model using Markov chain Monte Carlo (MCMC) sampling. We use BEAGLE in conjunction with BEAST to improve the computational performance of our analyses 33 . MCMC chains were run for 50,000,000 generations, sampling every 5,000 generations. We diagnosed the runs by examining trace plots and effective samples sizes, and summarized continuous parameters (mean and 95% highest posterior density (HPD) intervals) using Tracer (http://tree.bio.ed.ac.uk/software/tracer/) after discarding a 10% burn-in. Trees were summarized as maximum clade credibility trees using TreeAnnotator and visualized in FigTree (http://tree.bio.ed.ac.uk/software/figtree/).
In two specific phylogeographic analyses, we assessed (i) to what extent sequences sampled early in the US epidemic characterize the subtype B diversity in the US clade (Extended Data Fig. 6a) and (ii) to what extent the location state at the origin of the US clade can be estimated using sequences sampled later in the epidemic from three different US states (Extended Data Fig. 6b) . For this purpose, we first reconstructed time-measured phylogenies for the env 133 data set using the substitution model, molecular clock model and coalescent model described above and subsequently reconstructed ancestral locations on the inferred posterior distribution of trees.
For Extended Data Fig. 6a , we classified US sequences as 'early' or 'late' depending on whether they were sampled before or after (and including) 1985. For Extended Data Fig. 6b , we first pruned the necessary US sequences from the posterior distributions in order to retain only 'late' sequences from New York, North Carolina and California (matching the sampling from New York, Georgia and California in Fig. 3 and Extended Data Fig. 5b ). In this case, the support for a NYC ancestral state is likely upheld by the presence of two basal NYC representatives, but location estimates in a star-like tree structure with long tip branches will be critically dependent on how well the diversity of any location is represented in the contemporaneous sampling, as recently noted 34 .
Comparison of phylogeographic estimates before and after deleting minor recombinant regions from putative recombinants (Extended Data 
